Assessing the Effectiveness of Rhomboid Intercostal and Erector Spinae Plane Blocks After Lung Cancer Thoracotomy
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• patients undergoing thoracotomy for lung cancer
⁃ Age ≥ 18 years and ≤ 65 years
⁃ ASA physical status II or III
⁃ Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m²
⁃ Willing and able to provide informed consent
Locations
Other Locations
Egypt
National Cancer Institute - Cairo University
RECRUITING
Cairo
Contact Information
Primary
Sayed M Abed, MD
sayed.abed@nci.cu.edu.eg
+20 122 680 6532
Time Frame
Start Date: 2025-07-01
Estimated Completion Date: 2026-08-01
Participants
Target number of participants: 60
Treatments
Experimental: Ultrasound-guided Rhomboid Intercostal Block
Patients in this group will receive a rhomboid intercostal block with 20-25 mL of 0.25% bupivacaine injected between the rhomboid major and intercostal muscles under ultrasound guidance 30-45 minutes before surgery.
Active_comparator: Ultrasound-guided Erector Spinae Plane Block
Patients in this group will receive an erector spinae plane block with 20-25 mL of 0.25% bupivacaine injected deep to the erector spinae muscle at the T4-T5 level under ultrasound guidance 30-45 minutes before surgery.
Related Therapeutic Areas
Sponsors
Leads: Cairo University